David Fleischer - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock David Fleischer's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
David Fleischer

David Fleischer

Verified

Planner, IBI Group

Vaughan

Final Covers

News , Opinions, Movies, Comics , Reviews, Art , Video Games

Doesn’t Cover

ScienceFinanceTech

Journalist Type

Seniority Positions

Industries

-

Medium Formats

Content

Total articles 95

  • Response to peanut patch treatment increases through 60 months

    By Richard Gawel Verified, Kristen Dowd Verified, David Fleischer| Healio Allergy/Asthma Verified Key takeaways: The VP250 VIASKIN Peanut patch includes 250 µg of peanut protein. Percentages of children who achieved a 1,000 mg eliciting dose increased. Levels of peanut-specific IgE and IgG4 levels decreased and increased. SAN DIEGO — Percentages of children with peanut allergy who responded to treatment with the VP250 VIASKIN Peanut patch from DBV Technologies increased from 12 months through 60 months, according to an abstract presented here.

    By Richard Gawel Verified, Kristen Dowd Verified, David Fleischer · Healio Allergy/Asthma

    Mar. 05, 2025

  • Physicians Have Unique Door-Knocking Skills to Offer in this Election

    By Norbert Goldfield, David Fleischer| MedCentral@ At the Democratic National Convention, there was a great deal of talk about the role of neighbors.

    By Norbert Goldfield, David Fleischer · MedCentral

    Sep. 11, 2024

  • Response to peanut patch treatment increases through 60 months

    By Richard Gawel Verified, Kristen Dowd Verified, David Fleischer| Healio Allergy/Asthma Verified Key takeaways: The VP250 VIASKIN Peanut patch includes 250 µg of peanut protein. Percentages of children who achieved a 1,000 mg eliciting dose increased. Levels of peanut-specific IgE and IgG4 levels decreased and increased. SAN DIEGO — Percentages of children with peanut allergy who responded to treatment with the VP250 VIASKIN Peanut patch from DBV Technologies increased from 12 months through 60 months, according to an abstract presented here.

    By Richard Gawel Verified, Kristen Dowd Verified, David Fleischer · Healio Allergy/Asthma

    Mar. 05, 2025

As seen in